• Vertex Pharmaceuticals (MA) (VRTX)'s Sales Force Gears Up to Battle Rivals More...
• Watson Pharmaceuticals, Inc. (WPI) Acquires Specifar Pharma for $562 Million More...
• Trius Therapeutics Announces Pricing of $30 Million Financing More...
• Elan Corporation PLC (ELN) Makes Investment in Proteostasis Therapeutics, Inc. as Part of $50 Million Neurodegenerative Drug Discovery Partnership More...
• PsychoGenics Inc. and Evotec AG (EVTG.F) Enter into a Strategic Alliance to Provide Integrated CNS Drug Discovery Solutions More...
• Cancer Research UK Signs Deal With Centella Therapeutics, Inc. to Launch Clinical Development of Radiotherapy-Enhancing Drug More...
• Vanguard EMS and Tektronix Component Solutions Establish Joint Marketing Agreement More...
• Dr. David Heimbrook Appointed Chief Executive Officer of SAIC-Frederick, Inc. (SAI) More...
• Biocryst Pharmaceuticals (BCRX) Announces Appointment of Thomas Staab as Its Next Chief Financial Officer More...
• Patrick Hwu, M.D., and Mario Sznol, M.D., Join Genesis Biopharma, Inc.'s Scientific and Medical Advisory Board More...
• International Stem Cell Corporation Reports First Quarter Revenue of $1.5 Million on Strong Initial Sales of Skin Care Products and Strong Growth of Research Product Sales More...
• Jiangbo Pharmaceuticals, Inc. (Formerly known as Genesis Pharmaceuticals Enterprises, Inc.) Announces Third Quarter Fiscal Year 2011 Results More...
• Pfizer Inc. (PFE) will Invest $21 Million in US Injectables Upgrade More...
• Deaths in Pfizer Inc. (PFE) Arthritis Trial Under Microscope More...
• Novartis Corporation (NVS) Drug Gives Pain Relief in Gouty Arthritis in Two Phase III Trials More...
• Bayer AG (BAY.F), Johnson & Johnson (JNJ)'s Xarelto Prevented Repeat Strokes in Analysis More...
• FDA Approves Trial of Pathway Therapeutics Limited Cancer Drug; $7.5 Million Financing in Place to Advance Novel PI3K/mTOR Inhibitor Portfolio More...
• Roche (RHHBY) Leads Deadly Skin Cancer Turnaround to "Golden Age" of Drug Research More...
• Injection Therapy for Sudden Hearing Loss Disorder May Be Suitable Alternative to Oral Steroids, Harvard Medical School Study More...
• New Drug Stops Aggressive Form of Childhood Leukemia, Weill Cornell Medical College and University of California, San Francisco (UCSF) Study More...
• Studies Show Crescendo Bioscience's Vectra(TM) DA Can Track Early Response to Rheumatoid Arthritis Therapy and Predict Joint Damage at the Molecular Level More...
• Watson Pharmaceuticals, Inc. (WPI) Acquires Specifar Pharma for $562 Million More...
• Trius Therapeutics Announces Pricing of $30 Million Financing More...
• Elan Corporation PLC (ELN) Makes Investment in Proteostasis Therapeutics, Inc. as Part of $50 Million Neurodegenerative Drug Discovery Partnership More...
• PsychoGenics Inc. and Evotec AG (EVTG.F) Enter into a Strategic Alliance to Provide Integrated CNS Drug Discovery Solutions More...
• Cancer Research UK Signs Deal With Centella Therapeutics, Inc. to Launch Clinical Development of Radiotherapy-Enhancing Drug More...
• Vanguard EMS and Tektronix Component Solutions Establish Joint Marketing Agreement More...
• Dr. David Heimbrook Appointed Chief Executive Officer of SAIC-Frederick, Inc. (SAI) More...
• Biocryst Pharmaceuticals (BCRX) Announces Appointment of Thomas Staab as Its Next Chief Financial Officer More...
• Patrick Hwu, M.D., and Mario Sznol, M.D., Join Genesis Biopharma, Inc.'s Scientific and Medical Advisory Board More...
• International Stem Cell Corporation Reports First Quarter Revenue of $1.5 Million on Strong Initial Sales of Skin Care Products and Strong Growth of Research Product Sales More...
• Jiangbo Pharmaceuticals, Inc. (Formerly known as Genesis Pharmaceuticals Enterprises, Inc.) Announces Third Quarter Fiscal Year 2011 Results More...
• Pfizer Inc. (PFE) will Invest $21 Million in US Injectables Upgrade More...
• Novartis Corporation (NVS) Drug Gives Pain Relief in Gouty Arthritis in Two Phase III Trials More...
• Bayer AG (BAY.F), Johnson & Johnson (JNJ)'s Xarelto Prevented Repeat Strokes in Analysis More...
• FDA Approves Trial of Pathway Therapeutics Limited Cancer Drug; $7.5 Million Financing in Place to Advance Novel PI3K/mTOR Inhibitor Portfolio More...
• Roche (RHHBY) Leads Deadly Skin Cancer Turnaround to "Golden Age" of Drug Research More...
• Injection Therapy for Sudden Hearing Loss Disorder May Be Suitable Alternative to Oral Steroids, Harvard Medical School Study More...
• New Drug Stops Aggressive Form of Childhood Leukemia, Weill Cornell Medical College and University of California, San Francisco (UCSF) Study More...
• Studies Show Crescendo Bioscience's Vectra(TM) DA Can Track Early Response to Rheumatoid Arthritis Therapy and Predict Joint Damage at the Molecular Level More...
( Source: Biospace )
0 comments